http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35518683

Outgoing Links

Predicate Object
contentType Journal Article
issn 2296-858X
pageRange 1168220-
publicationName Frontiers in Medicine
startingPage 1168220
bibliographicCitation Chen S, Yu Q, Jiang W, Lu Y, Zhao Y, Wang H. Rechallenge with EGFR-TKI after failure of immunotherapy is considered an effective treatment for advanced lung adenocarcinoma patients with EGFR exon 19 deletion: a case report. Front Med (Lausanne). 2023;10():1168220. PMID: 37457583; PMCID: PMC10339383.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_741734cd7dc29bb1028a5f74caeee1c9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9a031b00f1e71e8f049d5f3e5734807c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_40610d3c946588d9dafb85dc0f3d0cec
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db4944cd35f459828c5f24c6e38d7ed0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_08682b29e52d9502224eb480db7a5f70
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_97b9aad140d06eb2311044db0bb80351
date 2023-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC10339383
https://pubmed.ncbi.nlm.nih.gov/37457583
https://doi.org/10.3389/fmed.2023.1168220
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/43407
https://portal.issn.org/resource/ISSN/2296-858X
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Rechallenge with EGFR-TKI after failure of immunotherapy is considered an effective treatment for advanced lung adenocarcinoma patients with EGFR exon 19 deletion: a case report
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10184653
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22024915
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25017411
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148124
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3180f3560c702ffddc361716fecd9861
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID426756
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135410875
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7a0153350cba31da4ce6bfa8f8c68f72
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6650
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_966b69495aff24dd4bc4208192414e49

Total number of triples: 33.